share_log

Pieris Pharmaceuticals Announces Repositioning Plan To Optimize Potential Milestones And Royalties Including Discontinuation Of R&D Efforts And Workforce Reduction

Benzinga ·  Mar 27 08:06
Pieris Pharmaceuticals Announces Repositioning Plan To Optimize Potential Milestones And Royalties Including Discontinuation Of R&D Efforts And Workforce Reduction
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment